Evaluation of vaccination strategies during pandemic outbreaks

  1. (PDF, 833 KB)
  2. Get@NRC: Evaluation of vaccination strategies during pandemic outbreaks (Opens in a new window)
DOIResolve DOI: http://doi.org/10.3934/mbe.2011.8.113
AuthorSearch for: ; Search for: ; Search for:
Journal titleMathematical biosciences and engineering
Pages113122; # of pages: 10
SubjectPandemic influenza; vaccination strategies; vaccine efficacy; epidemic models; delay differential equations
AbstractDuring pandemic influenza, several factors could significantly impact the outcome of vaccination campaigns, including the delay in pandemic vaccine availability, inadequate protective efficacy, and insufficient number of vaccines to cover the entire population. Here, we incorporate these factors into a vaccination model to investigate and compare the effectiveness of the single-dose and two-dose vaccine strategies. The results show that, if vaccination starts early enough after the onset of the outbreak, a two-dose strategy can lead to a greater reduction in the total number of infections. This, however, requires the second dose of vaccine to confer a substantially higher protection compared to that induced by the first dose. For a sufficiently long delay in start of vaccination, the single-dose strategy outperforms the two-dose vaccination program regardless of its protection efficacy. The findings suggest that the population-wide benefits of a single-dose strategy could in general be greater than the two-dose vaccination program, in particular when the second dose offers marginal increase in the protection induced by the first dose.
Publication date
AffiliationNRC Institute for Biodiagnostics; National Research Council Canada
Peer reviewedYes
NPARC number19726582
Export citationExport as RIS
Report a correctionReport a correction
Record identifier9269ee75-e8ad-4e16-94f7-1e362d46318e
Record created2012-03-28
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)